history of glp 1 agonists glp-1 A timeline of GLP- discovery and clinical development. Created in GLP-1 Agonists - What is

Longer-term metabolic benefits, including effects on body composition and insulin sensitivity, typically emerge over months of consistent daily consumption, consistent with the timeframes seen in trials like PREDIMED (median follow-up of 4.8 years)

Especially for older adults who have the most to gain from a drug that lowers the risk of heart disease but also need to preserve muscle strength combining a muscle-preserving drug with GLP-1 agonists could be a big deal

10.1038/362075a0 [DOI] [PubMed] [Google Scholar] 52.Han WN, Hlscher C, Yuan L, Yang W, Wang XH, Wu MN, et al

57 , R93r108 (2016)

Trulicity was first approved in 2014 in the US for treating Type 2 diabetes